Manufactures dietary supplements and nutraceutical products.
Jun 2026Revenue $43.9M/yrExpenses $46.6M/yr
Fell below break-even Jan 2026
Figures by year
When will Integrated Biopharma be profitable again?
Its expenses passed its revenue in Jan 2026. In the 12 months to Jun 2026, revenue was $43.9M and expenses $46.6M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jun 2026 | $43.9M | $46.6M | −$2.71M |
| Jun 2025 | $54.4M | $52.3M | $2.02M |
| Jun 2024 | $50.3M | $50.1M | $251K |
| Jun 2023 | $50.7M | $50.6M | $120K |
| Jun 2022 | $56.2M | $53.5M | $2.75M |
| Jun 2021 | $63.6M | $57.8M | $5.78M |
| Jun 2020 | $52.8M | $49.5M | $3.26M |
| Jun 2019 | $50.0M | $47.3M | $2.70M |
| Jun 2018 | $43.7M | $42.0M | $1.69M |
| Jun 2017 | $47.0M | $43.8M | $3.19M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.